Physiological Pacing for AV Block to Prevent Pacemaker-induced Cardiomyopathy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-100
SponsorHospital Clinic of Barcelona
About this trial
The implantation of a pacemaker and conventional cardiac pacing from the right ventricle (apex or septum) is an effective and safe therapy for the treatment of patients with atrioventricular block and bradycardia.
Eligibility criteria
Qualifiers
The patient must be ≥ 18 years of age.
The patient must indicate their acceptance to participate in the study by signing an informed consent document.
Patients with EF> 50% and indication for pacemaker implantation due to atrial-ventricular block according to current clinical guidelines.
Disqualifiers
Inability to understand and sign the informed consent.
Patients with severe comorbidities and life expectancy <1 year.
Patients with severe cognitive impairment or other comorbidities resulting in dependence for basic activities of daily life.
Patients who cannot come to our center to carry out the follow-up of the study.
Trial design
Treatments tested in this trial
- Pacemaker implantation and conventional cardiac pacing
- Conduction system pacing implant
Treatment groups
200 Participants
are divided into 2 treatment groupsSponsors and collaborators
Hospital Clinic of Barcelona
Lead sponsor
Institut d'Investigacions Biomèdiques August Pi i Sunyer
Collaborator
Consorcio Centro de Investigación Biomédica en Red (CIBER)
Collaborator
Source ClinicalTrials.gov